世界のパシレオチド市場予測2023-2029:0.3mg/ml、0.6mg/ml、0.9mg/ml

【英語タイトル】Pasireotide Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23JU5876)・商品コード:MMG23JU5876
・発行会社(調査会社):Market Monitor Global
・発行日:2023年6月
・ページ数:79
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥474,500見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥616,850見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥711,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のパシレオチド市場規模と予測を収録しています。・世界のパシレオチド市場:売上、2018年-2023年、2024年-2029年
・世界のパシレオチド市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のパシレオチド市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「0.3mg/ml」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

パシレオチドのグローバル主要企業は、Novartisなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、パシレオチドのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のパシレオチド市場:タイプ別、2018年-2023年、2024年-2029年
世界のパシレオチド市場:タイプ別市場シェア、2022年
・0.3mg/ml、0.6mg/ml、0.9mg/ml

世界のパシレオチド市場:用途別、2018年-2023年、2024年-2029年
世界のパシレオチド市場:用途別市場シェア、2022年
・病院、薬局

世界のパシレオチド市場:地域・国別、2018年-2023年、2024年-2029年
世界のパシレオチド市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるパシレオチドのグローバル売上、2018年-2023年
・主要企業におけるパシレオチドのグローバル売上シェア、2022年
・主要企業におけるパシレオチドのグローバル販売量、2018年-2023年
・主要企業におけるパシレオチドのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Novartis

*************************************************************

・調査・分析レポートの概要
パシレオチド市場の定義
市場セグメント
世界のパシレオチド市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のパシレオチド市場規模
世界のパシレオチド市場規模:2022年 VS 2029年
世界のパシレオチド市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのパシレオチドの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のパシレオチド製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:0.3mg/ml、0.6mg/ml、0.9mg/ml
パシレオチドのタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、薬局
パシレオチドの用途別グローバル売上・予測

・地域別市場分析
地域別パシレオチド市場規模 2022年と2029年
地域別パシレオチド売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Novartis
...

Pasireotide is an orphan drug approved in the United States and Europe for the treatment of Cushing’s disease in patients who fail or are ineligible for surgical therapy.
This report aims to provide a comprehensive presentation of the global market for Pasireotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pasireotide. This report contains market size and forecasts of Pasireotide in global, including the following market information:
Global Pasireotide Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pasireotide Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Pasireotide companies in 2022 (%)
The global Pasireotide market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
0.3mg/ml Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pasireotide include Novartis. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pasireotide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pasireotide Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pasireotide Market Segment Percentages, by Type, 2022 (%)
0.3mg/ml
0.6mg/ml
0.9mg/ml
Global Pasireotide Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pasireotide Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Global Pasireotide Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pasireotide Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pasireotide revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pasireotide revenues share in global market, 2022 (%)
Key companies Pasireotide sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Pasireotide sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pasireotide, market overview.
Chapter 2: Global Pasireotide market size in revenue and volume.
Chapter 3: Detailed analysis of Pasireotide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pasireotide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pasireotide capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Pasireotide Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pasireotide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pasireotide Overall Market Size
2.1 Global Pasireotide Market Size: 2022 VS 2029
2.2 Global Pasireotide Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pasireotide Sales: 2018-2029
3 Company Landscape
3.1 Top Pasireotide Players in Global Market
3.2 Top Global Pasireotide Companies Ranked by Revenue
3.3 Global Pasireotide Revenue by Companies
3.4 Global Pasireotide Sales by Companies
3.5 Global Pasireotide Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pasireotide Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pasireotide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pasireotide Players in Global Market
3.8.1 List of Global Tier 1 Pasireotide Companies
3.8.2 List of Global Tier 2 and Tier 3 Pasireotide Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Pasireotide Market Size Markets, 2022 & 2029
4.1.2 0.3mg/ml
4.1.3 0.6mg/ml
4.1.4 0.9mg/ml
4.2 By Type – Global Pasireotide Revenue & Forecasts
4.2.1 By Type – Global Pasireotide Revenue, 2018-2023
4.2.2 By Type – Global Pasireotide Revenue, 2024-2029
4.2.3 By Type – Global Pasireotide Revenue Market Share, 2018-2029
4.3 By Type – Global Pasireotide Sales & Forecasts
4.3.1 By Type – Global Pasireotide Sales, 2018-2023
4.3.2 By Type – Global Pasireotide Sales, 2024-2029
4.3.3 By Type – Global Pasireotide Sales Market Share, 2018-2029
4.4 By Type – Global Pasireotide Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Pasireotide Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application – Global Pasireotide Revenue & Forecasts
5.2.1 By Application – Global Pasireotide Revenue, 2018-2023
5.2.2 By Application – Global Pasireotide Revenue, 2024-2029
5.2.3 By Application – Global Pasireotide Revenue Market Share, 2018-2029
5.3 By Application – Global Pasireotide Sales & Forecasts
5.3.1 By Application – Global Pasireotide Sales, 2018-2023
5.3.2 By Application – Global Pasireotide Sales, 2024-2029
5.3.3 By Application – Global Pasireotide Sales Market Share, 2018-2029
5.4 By Application – Global Pasireotide Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Pasireotide Market Size, 2022 & 2029
6.2 By Region – Global Pasireotide Revenue & Forecasts
6.2.1 By Region – Global Pasireotide Revenue, 2018-2023
6.2.2 By Region – Global Pasireotide Revenue, 2024-2029
6.2.3 By Region – Global Pasireotide Revenue Market Share, 2018-2029
6.3 By Region – Global Pasireotide Sales & Forecasts
6.3.1 By Region – Global Pasireotide Sales, 2018-2023
6.3.2 By Region – Global Pasireotide Sales, 2024-2029
6.3.3 By Region – Global Pasireotide Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Pasireotide Revenue, 2018-2029
6.4.2 By Country – North America Pasireotide Sales, 2018-2029
6.4.3 US Pasireotide Market Size, 2018-2029
6.4.4 Canada Pasireotide Market Size, 2018-2029
6.4.5 Mexico Pasireotide Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Pasireotide Revenue, 2018-2029
6.5.2 By Country – Europe Pasireotide Sales, 2018-2029
6.5.3 Germany Pasireotide Market Size, 2018-2029
6.5.4 France Pasireotide Market Size, 2018-2029
6.5.5 U.K. Pasireotide Market Size, 2018-2029
6.5.6 Italy Pasireotide Market Size, 2018-2029
6.5.7 Russia Pasireotide Market Size, 2018-2029
6.5.8 Nordic Countries Pasireotide Market Size, 2018-2029
6.5.9 Benelux Pasireotide Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Pasireotide Revenue, 2018-2029
6.6.2 By Region – Asia Pasireotide Sales, 2018-2029
6.6.3 China Pasireotide Market Size, 2018-2029
6.6.4 Japan Pasireotide Market Size, 2018-2029
6.6.5 South Korea Pasireotide Market Size, 2018-2029
6.6.6 Southeast Asia Pasireotide Market Size, 2018-2029
6.6.7 India Pasireotide Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Pasireotide Revenue, 2018-2029
6.7.2 By Country – South America Pasireotide Sales, 2018-2029
6.7.3 Brazil Pasireotide Market Size, 2018-2029
6.7.4 Argentina Pasireotide Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Pasireotide Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Pasireotide Sales, 2018-2029
6.8.3 Turkey Pasireotide Market Size, 2018-2029
6.8.4 Israel Pasireotide Market Size, 2018-2029
6.8.5 Saudi Arabia Pasireotide Market Size, 2018-2029
6.8.6 UAE Pasireotide Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Pasireotide Major Product Offerings
7.1.4 Novartis Pasireotide Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
8 Global Pasireotide Production Capacity, Analysis
8.1 Global Pasireotide Production Capacity, 2018-2029
8.2 Pasireotide Production Capacity of Key Manufacturers in Global Market
8.3 Global Pasireotide Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pasireotide Supply Chain Analysis
10.1 Pasireotide Industry Value Chain
10.2 Pasireotide Upstream Market
10.3 Pasireotide Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pasireotide Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



★調査レポート[世界のパシレオチド市場予測2023-2029:0.3mg/ml、0.6mg/ml、0.9mg/ml] (コード:MMG23JU5876)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のパシレオチド市場予測2023-2029:0.3mg/ml、0.6mg/ml、0.9mg/ml]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆